Novo Nordisk reported DKK37.36B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Bausch Health Companies USD 1.08B 238M Jun/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Novo Nordisk DKK 37.36B 2.64B Jun/2026
Novo Nordisk DKK 37.36B 31.84B Jun/2026
Pacira USD 48.67M 8.43M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Supernus Pharmaceuticals USD 31.6M 2.37M Jun/2026